Back
Purple Innovation Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
12
PRPL
Purple Innovation
Last Price:
1.07
Seasonality Move:
0.45%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
151.43
Seasonality Move:
6.54%
Sell
12
Purple Innovation (PRPL)
is a Sell
Is Purple Innovation a Buy, Sell or Hold?
- The current Purple Innovation [PRPL] share price is $1.05. The Score for PRPL is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- PRPL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $148.89. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRPL Stock Price Chart
What is Purple Innovation's stock price today?
-
The Purple Innovation share price today is $1.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPL is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $148.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
PRPL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 43.74 | Sell |
| Chaikin Money Flow: | -94818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.21) | Sell |
| Bollinger Bands (100): | (1.02 - 1.42) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 68.26 | Buy |
| Chaikin Money Flow: | 280060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.33 - 143.31) | Buy |
| Bollinger Bands (100): | (125.42 - 139.7) | Buy |
PRPL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.04 | Buy |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.18 | Sell |
| 200-day SMA: | 1.28 | Sell |
| 8-day EMA: | 1.06 | Sell |
| 20-day EMA: | 1.09 | Sell |
| 50-day EMA: | 1.15 | Sell |
| 200-day EMA: | 1.42 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.6 | Buy |
| 20-day SMA: | 130.69 | Buy |
| 50-day SMA: | 132.91 | Buy |
| 200-day SMA: | 135.36 | Buy |
| 8-day EMA: | 133.29 | Buy |
| 20-day EMA: | 130.71 | Buy |
| 50-day EMA: | 131.94 | Buy |
| 200-day EMA: | 129.45 | Buy |
Purple Innovation Earnings Growth & PRPL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.05 per share, an increase this year of $0.19 per share, and an increase next year of $0.24 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $1.52 per share, an increase this year of $1.66 per share, and an increase next year of $4.42 per share.
Purple Innovation Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||